ライフサイエンスコーパス: adolescent and young adult

1 h 9 met inclusion criteria (comprising 17389 adolescents and young adults).

2 uscle in typically developing preadolescent, adolescent, and young adults.

3 Energy drinks are popular among adolescents and young adults.

4 osis-risk studies have examined help-seeking adolescents and young adults.

5 rategy can be extended successfully to older adolescents and young adults.

6 as associated with increased odds of pain in adolescents and young adults.

7 ound cell tumor (DSRCT) is a rare sarcoma in adolescents and young adults.

8 s the most common primary bone malignancy of adolescents and young adults.

9 le-nucleotide polymorphism at this locus) in adolescents and young adults.

10 nd especially with chronic multisite pain in adolescents and young adults.

11 nical care, particularly in the treatment of adolescents and young adults.

12 ns between CRP and depression in a sample of adolescents and young adults.

13 creasingly popular recreational drug amongst adolescents and young adults.

14 t lethal liver cancer that primarily affects adolescents and young adults.

15 ives to reduce risk factors for stroke among adolescents and young adults.

16 We primarily report the comparison between adolescents and young adults.

17 dren younger than 12 years is faster than in adolescents and young adults.

18 IV results were analyzed for 6,940 Tanzanian adolescents and young adults.

19 egies to prevent long-term weight gain among adolescents and young adults.

20 and carotid intima-media thickness (cIMT) in adolescents and young adults.

21 re based on asthma guidelines for inner-city adolescents and young adults.

22 impact on cardiac structure and function in adolescents and young adults.

23 obacco, alcohol, and drug use, are common in adolescents and young adults.

24 ms, particularly substance use disorders, in adolescents and young adults.

25 ia and sudden cardiac death, particularly in adolescents and young adults.

26 d bulimia nervosa are common problems facing adolescents and young adults.

27 t-tissue malignancies occurring primarily in adolescents and young adults.

28 alexithymia and anxiety among food-allergic adolescents and young adults.

29 use of sudden cardiac death, particularly in adolescents and young adults.

30 HCC was measured in 671 adolescents and young adults.

31 gh as that of group A Streptococcus (GAS) in adolescents and young adults.

32 ations, and management of type 2 diabetes in adolescents and young adults.

33 l cannabis is recognized as a niche drug for adolescents and young adults.

34 ccurring at any age with a peak incidence in adolescents and young adults.

35 s and decrease the appeal of e-cigarettes to adolescents and young adults.

36 n treatment for more than 400 000 additional adolescents and young adults.

37 of new smokers but not current smokers among adolescents and young adults.

38 ke but also contribute to less smoking among adolescents and young adults.

39 he emergence of type 2 diabetes in children, adolescents, and young adults.

40 part to perinatally HIV-1-infected children, adolescents, and young adults.

41 soft-tissue sarcomas that arise in children, adolescents, and young adults.

42 e the leading cause of death among children, adolescents, and young adults.

43 elated, highly malignant tumors of children, adolescents, and young adults.

44 of PTSD reexperiencing symptoms in children, adolescents, and young adults.

45 a group of 35 normally developing children, adolescents, and young adults.

46 Participants were healthy children, adolescents, and young adults.

47 ences in policy needs for infants, children, adolescents, and young adults.

48 e tumor that most commonly affects children, adolescents, and young adults.

49 Patients of interest included children, adolescents, and young adults 10 years or older.

50 Among 2014 healthy children, adolescents, and young adults (1022 [50.7%] female and 4

51 timating equations in a cross-section of 751 adolescents and young adults (1054 measurements), using

52 a immunization campaign, targeting children, adolescents, and young adults 2-20 years old, was conduc

53 ent of acute lymphoblastic leukemia in older adolescents and young adults, adopting therapeutic strat

54 ections and autoinflammation), 25 (45%) were adolescents and young adults (age 14-39 years).

55 y to determine the site of care of children, adolescents, and young adults (age 0 to 24 years) with n

56 Participants included 41 adolescents and young adults aged 12 to 19 years with MD

57 The USPSTF recommends counseling children, adolescents, and young adults aged 10 to 24 years who ha

58 All children, adolescents, and young adults aged 8 to 20 years with du

59 pective, longitudinal epidemiologic study of adolescents and young adults (aged 14-24 years) in Munic

60 prevalence increased from 1995 to 2008 among adolescents and young adults (aged 15-44 years) hospital

61 Children, adolescents, and young adults ages 0 to 29 years with ne

62 sful memory retrieval of scenes in children, adolescents, and young adults ages 8-21 via functional m

63 (fMRI) to examine VSWM function in children, adolescents, and young adults, ages 7-22.

64 diversion of prescription stimulants in ADHD adolescents and young adults and indicate that extended-

65 opoietic stem-cell transplantation (HSCT) in adolescents and young adults and patients with high-risk

66 y, diverse, longitudinal cohort of children, adolescents, and young adults and to test for difference

67 s allele on the development of alcoholism in adolescents and young adults, and demonstrated a signifi

68 and adult soft tissue sarcomas diagnosed in adolescents and young adults, and discuss the age-specif

69 Anorexia nervosa is prevalent in adolescents and young adults, and endocrine changes incl

70 Short sleep duration is common in adolescents and young adults, and short sleep duration i

71 gned to decrease sexual risk behaviors among adolescents and young adults, and their impact on youth'

72 Suicide rates for adolescents and young adults are higher in rural than in

73 e literature; however, patients diagnosed as adolescents and young adults are not well represented in

74 ency virus type 1 (HIV-1)-infected children, adolescents, and young adults are unknown.

75 diabetes of youth (MODY) occurs in children, adolescents and young adults as a non-insulin-requiring

76 n part to the unique developmental issues of adolescents and young adults as well as the complexity a

77 ft tissue malignancy with a predilection for adolescents and young adults, associates consistently wi

78 egative emotional traits, and alcohol use in adolescents and young adults at high risk for alcoholism

79 Recent studies of adolescents and young adults at high risk for developing

80 tween children and older adults, the care of adolescent and young adult (AYA) patients with acute lym

81 The delivery of quality care for adolescent and young adult (AYA) patients with cancer an

82 Because adolescent and young adult (AYA) patients with cancer ha

83 for health care professionals who work with adolescent and young adult (AYA) patients with cancer.

84 st 2 years after initial cancer diagnosis in adolescent and young adult (AYA) patients with cancer.

85 OSE The purpose of this study was to compare adolescent and young adult (AYA) pediatric cancer surviv

86 ion-based evidence regarding outcomes of the adolescent and young adult (AYA) population with gastroi

87 and in conjunction with adult groups for the adolescent and young adult (AYA) population with HL.

88 Preservation of fertility is important to adolescent and young adult (AYA) survivors of cancer.

89 Adolescents and young adults (AYA) with cancer have been

90 To assess the survival impact of SPMs in adolescents and young adults (AYAs) (15-39 years) compar

91 lete remission (CR) rate, and outcome of 321 adolescents and young adults (AYAs) ages 16 to 20 years

92 ological and social outcomes of HIV-infected adolescents and young adults (AYAs) before and after tra

93 Adolescents and young adults (AYAs) diagnosed with cance

94 ost common cause of disease-related death in adolescents and young adults (AYAs) in high-income count

95 Progression of melanoma to distant sites in adolescents and young adults (AYAs) is not reliably pred

96 se (NAFLD) is a significant health burden in adolescents and young adults (AYAs) which has substantia

97 ous symptoms, and attitude toward illness in adolescents and young adults (AYAs) with allergies.

98 Adolescents and young adults (AYAs) with cancer are a di

99 leading disease-related cause of death among adolescents and young adults (AYAs), but little is known

100 n; however, it presents unique challenges in adolescents and young adults (AYAs).

101 E have consistently shown lower survival for adolescents and young adults (AYAs; aged 15-24 years) th

102 n women between the ages of 15 and 39 years (adolescents and young adults [AYAs]) constitutes 5% to 6

103 Among this large cohort of adolescents and young adults, binge eating was more comm

104 C ratio similar findings were observed among adolescents and young adults (birth cohort), and then re

105 sychotic use increased from 2006 to 2010 for adolescents and young adults but not for children aged 1

106 e observed between maternal pain and pain in adolescents and young adults, but no association was fou

107 l incidence of suicide attempt was higher in adolescents and young adults, but the time pattern was t

108 ietal EM effect) were recruited by children, adolescents and young adults, but to a much lesser exten

109 Rates of smoking are increasing among adolescents and young adults, but trends in smoking amon

110 licate the difficult adjustments required in adolescents and young adults by virtue of their morbidit

111 To compare the birth outcomes of adolescent and young adult cancer survivors (AYA [diagno

112 t disease burden experienced by survivors of adolescent and young adult cancer.

113 ow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer (COG-LTFU Guidelines)

114 ow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer (COG-LTFU Guidelines)

115 hysical sexual dysfunction in male pubertal, adolescent, and young adult cancer survivors.

116 Survivors of adolescent and young adult cancers are at risk for treat

117 ow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers are risk-based, expo

118 complications after treatment for childhood, adolescent, and young adult cancers.

119 complications after treatment for childhood, adolescent, and young adult cancers.

120 HIV prevalence in adolescents and young adults cannot be used as a surroga

121 nant cancer of bone and particularly affects adolescents and young adults, causing debilitation and s

122 ations for gonadotoxicity in male childhood, adolescent, and young adult (CAYA) cancer survivors.

123 Female survivors of childhood, adolescent, and young adult (CAYA) cancer who were treat

124 The adolescent and young adult chimpanzees had the largest b

125 mbination EIA (enzyme immunoassay) within an adolescent and young-adult cohort in northwest Tanzania.

126 al studies have examined the extent to which adolescents and young adults (collectively termed youth)

127 Adolescents and young adults continue to have the second

128 come measure was chronic nonspecific pain in adolescents and young adults, defined as pain in at leas

129 in the prevalence of mental disorders among adolescents and young adults depending on whether the es

130 The putative link between adolescent and young adult depression was not supported.

131 The majority of children, adolescents, and young adults diagnosed with cancer will

132 ults and in children ages <12 years, whereas adolescents and young adults do not derive an optimal be

133 ctively to decrease sexual risk behaviors in adolescents and young adults, especially when complement

134 Numerous studies have examined the adolescent and young adult fate of children with attenti

135 This study found significant reductions in adolescent and young adult female mortality rates, evide

136 ic resonance imaging data were acquired from adolescent and young adult female patients with acute AN

137 SLPI in 215 vaginal specimens collected from adolescent and young adult females aged 14-22 years.

138 strategy for long-term weight control among adolescents and young adult females.

139 ts of BMI on 82 metabolic measures in 12,664 adolescents and young adults from four population-based

140 ng the prevalence of periodontal outcomes in adolescents and young adults from two population-based b

141 CI, 28%-62%) of tumors from patients in the adolescent and young adult group (14 of 32), in 17% (95%

142 CI, 50%-100%) of tumors from patients in the adolescent and young adult group (5 of 5), in 17% (95% C

143 CI, 17%-54%) of tumors from patients in the adolescent and young adult group (9 of 27), in 16% (95%

144 The treatment of the adolescent and young adult group is delineated, and the

145 months), children (18 months-<12 years), and adolescents and young adults (>/=12 years).

146 tensive combination chemotherapy regimens in adolescents and young adults has significantly improved

147 Adolescents and young adults have benefited from the epi

148 A substantial proportion of adolescents and young adults have cross-reactive antibod

149 Data are from the Adolescent and Young Adult Health Outcomes and Patient E

150 l ethanol exposure and the risk for abuse in adolescent and young adult humans.

151 wed some increase in bone mineral density of adolescents and young adults in areas with fluoridated w

152 ence of Hodgkin lymphoma has increased among adolescents and young adults in recent decades, but the

153 ectively reduced the occurrence of AHB among adolescents and young adults in Taiwan for >25 years, ma

154 Atheromas, which emerge in some adolescents and young adults in the same locations, have

155 Recent estimates indicate that 6.5 million adolescents and young adults in the United States are ne

156 prospectively examined the mental health of adolescents and young adults in this vulnerable populati

157 f brain development in 628 healthy children, adolescents, and young adults in the large-scale multice

158 have explored survival differences by sex in adolescents and young adults, in whom melanoma is the th

159 lth needs of young people in transition (old adolescents and young adults), including those of young

160 nspecific pain and chronic multisite pain in adolescents and young adults increased when both parents

161 nce is highest in studies that have included adolescents and young adults, individuals with moderate

162 in-Barr virus infection manifesting as IM in adolescents and young adults is a risk factor for MS.

163 The prevalence of type 2 diabetes in adolescents and young adults is dramatically increasing.

164 the burden of disease and health risks among adolescents and young adults is likely to change substan

165 sed equations to obtain the estimated GFR in adolescents and young adults is poorly understood.

166 tension (PH) in neonates, infants, children, adolescents, and young adults is a complex condition tha

167 Adolescent and young adult lesbians may be less likely t

168 Although adolescent and young adult males accounted for fewer ove

169 Adolescent and young adult males were 55% more likely to

170 cortical thickness between high-functioning adolescent and young adult males with autism spectrum di

171 warnings regarding suicidality in children, adolescents, and young adults may have had an effect on

172 with accelerated coronary atherosclerosis in adolescent and young adult men.

173 tions (aged 18-90) and those observed in our adolescent and young adult meta-analysis.

174 UK has not matched the gains made in child, adolescent, and young adult mortality by other comparabl

175 quasi-experimental study was conducted; 512 adolescents and young adults newly enrolling in one empl

176 he Third and Fourth International Childhood, Adolescent and Young Adult NHL Symposia to review existi

177 n 2009 at the Third International Childhood, Adolescent and Young Adult NHL Symposium to develop a re

178 nspecific pain and chronic multisite pain in adolescents and young adults (odds ratio, 1.5; 95% CI, 1

179 lines-based therapy for inner-city children, adolescents, and young adults, omalizumab further improv

180 trong Foundation program and a result of the Adolescent and Young Adult Oncology Progress Review Grou

181 re questionnaire data were available for 701 adolescents and young adults participating in the multic

182 Treatment with BOS was well tolerated in adolescent and young adult patients with EoE and resulte

183 Survival outcomes for adolescent and young adult patients with soft tissue sar

184 trol, targeted, metabolomic evaluation of 33 adolescent and young adult patients with well-characteri

185 trol, targeted, metabolomic evaluation of 33 adolescent and young adult patients with well-characteri

186 Recent data suggest that in adolescents and young adults (persons aged 15 to 24 year

187 Adolescent and young adult pharyngitis is more complicat

188 ent physicians should know the red flags for adolescent and young adult pharyngitis: worsening sympto

189 s, management, and treatment options for the adolescent and young adult population.

190 quency of DSM-III-R personality disorders in adolescent and young adult psychiatric inpatients.

191 The prevalence of DSPD in adolescents and young adults ranges from 1 to 16%.

192 nitiation of sexual behavior is common among adolescents and young adults, some individuals express t

193 Although most sudden deaths occurred in adolescents and young adults, such catastrophes were not

194 Adolescent and young adult suicide attempters with bipol

195 The study sample was 223 adolescent and young adult survivors of childhood cancer

196 e of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymph

197 t of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymph

198 s a highly metastatic form of bone cancer in adolescents and young adults that is resistant to existi

199 Among 17389 adolescents and young adults, the ages ranged between 14

200 counts for 12% of sudden cardiac death among adolescents and young adults, the suspicion of this illn

201 n MOOC access and completion were larger for adolescents and young adults, the traditional ages where

202 erinatally HIV-1-infected children grow into adolescents and young adults, they are increasingly burd

203 Adolescent and young adult tobacco use was significantly

204 Transgender youth, including adolescent and young adult transgender women assigned a

205 Many adolescents and young adults use alternative tobacco pro

206 In this national sample of US adolescents and young adults, use of e-cigarettes at bas

207 Given the growing number of adolescents and young adults using employment training p

208 iffusion tensor images in twenty-one typical adolescents and young adults using the tract based spati

209 with resting state fMRI data from 58 healthy adolescent and young adult volunteers that points of max

210 A community-based sample of 4493 adolescents and young adults was used to define clinical

211 l study of 365 HIV-positive and HIV-negative adolescents and young adults, we examined the relation o

212 In 2003, all-cause mortality rates of adolescents and young adults were 403 and 1,613 per 100,

213 Survivors of the 10 most common cancers in adolescents and young adults were at significantly incre

214 adolescents and young adults were both represented; diag

215 In 2001-2002, 23.7% of female adolescents and young adults were trying to maintain the

216 tumor (DSRCT) is a rare disease of children, adolescents and young adults, which begins in the abdomi

217 y, were reported significantly more often by adolescents and young adults who combined energy drinks

218 In the meantime, adolescents and young adults who develop bacteremic symp

219 However, adolescents and young adults who have never smoked tradi

220 large US representative panel, we show that adolescents and young adults who report higher life sati

221 minants of exercise performance in children, adolescents and young adults who underwent the modified

222 find elevated probabilities among children, adolescents and young adults, whose contacts may be more

223 rocess of health care transition (HCT) among adolescent and young adults with special health care nee

224 The prognosis for older adolescents and young adults with acute lymphoblastic le

225 ures of response inhibition were obtained in adolescents and young adults with ADHD (N=185), their un

226 health records, we defined a cohort of 2479 adolescents and young adults with ADHD and 15865 without

227 is study compared the hippocampal volumes of adolescents and young adults with adolescent-onset alcoh

228 ine a genetic feature that is frequent among adolescents and young adults with ALL.

229 ions) in a well-characterized set of 40 male adolescents and young adults with autism and 40 age-, se

230 es in surface area) at high resolution among adolescents and young adults with autism spectrum disord

231 nd harms, antipsychotic medication use among adolescents and young adults with bipolar disorder is in

232 This study of adolescents and young adults with bipolar disorder with

233 pecific, this diagnosis can be considered in adolescents and young adults with characteristic imaging

234 verage 6 years after initial assessment, 110 adolescents and young adults with childhood ADHD (87 per

235 need for coordinated processes to transition adolescents and young adults with chronic conditions to

236 ogens on spatial and mechanical abilities in adolescents and young adults with congenital adrenal hyp

237 Particular attention is required in adolescents and young adults with exercise-associated sy

238 de, was found in a significant percentage of adolescents and young adults with familial hypercholeste

239 ral problems in an epidemiological sample of adolescents and young adults with food allergy; determin

240 Adolescents and young adults with GCTs often are treated

241 abetic ketoacidosis, and brittle diabetes in adolescents and young adults with IDDM.

242 s associated with worse survival among white adolescents and young adults with melanoma after control

243 ted cognition to functional MRI data from 71 adolescents and young adults with moderate to severe maj

244 oma (FL-HCC) is a rare liver tumor affecting adolescents and young adults with no history of primary

245 up of 7.5 years of 26,107 non-Hispanic white adolescents and young adults with primary invasive melan

246 ng of the causes of the survival gap between adolescents and young adults with sarcomas will help dri

247 Adolescents and young adults with secondary Hodgkin lymp

248 Pediatric providers are encouraged to ask adolescents and young adults with SHCN about their under

249 ackground regarding these health risks among adolescents and young adults with SHCN with particular f

250 Adolescents and young adults with special health care ne

251 Health care transition outcomes of adolescents and young adults with special health care ne

252 interaction between the amygdala and PFC in adolescents and young adults with these disorders.

253 Incentives to Improve Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes (BE IN

254 Among adolescents and young adults with type 1 diabetes, daily

255 monitoring adherence and glycemic control in adolescents and young adults with type 1 diabetes.

256 nicity of moxetumomab pasudotox in children, adolescents, and young adults with ALL (N = 55).

257 d with an increased risk of SAs in children, adolescents, and young adults with asthma.

258 k factors for hypovitaminosis D in children, adolescents, and young adults with CD.

259 to compare the vitamin D status of children, adolescents, and young adults with CF who were treated w

260 (OH)D concentrations remain low in children, adolescents, and young adults with CF.

261 ence, hospitalization is common in children, adolescents, and young adults with diabetes, primarily f

262 We enrolled inner-city children, adolescents, and young adults with persistent asthma in

263 nity to examine quality of life in children, adolescents, and young adults with type 1 diabetes and i

264 with insulin injection therapy in children, adolescents, and young adults with type 1 diabetes.

265 compared with injection therapy in children, adolescents, and young adults with type 1 diabetes.

266 isk markers across the metabolite profile in adolescents and young adults within the non-obese weight

267 Adolescents and young adults without childhood attention

268 ons (STIs) in a nonclinical cross-section of adolescent and young adult women.Methods.

269 substance use risk scores predicted whether adolescents and young adults would experience SV themsel

270 STIs disproportionately affect adolescents and young adults, yet timely diagnosis is of